Why is Datavault AI stock sliding today?
Datavault AI Inc. (DVLT) stock fell 10.3% pre-market to $0.347 after reporting a widened net loss of $18.36M in Q2 2026, with revenue far below its $200M annual goal. The company raised $25M via a convertible note and 15M shares, fueling dilution concerns, and faces a $94.5M acquisition amid cash shortages. Nasdaq delisting risk and a lawsuit also weigh on the stock.
How this was made
The 30-second read
Why it matters
The earnings miss and financing actions increase short‑term risk, but the acquisition could be a catalyst if executed.
Market read
The stock's steep pre‑market decline is driven by its own earnings and financing news, not broader market moves.
What to watch
Potential upside from Nasdaq bid‑price compliance if capital raise succeeds.
Background
Datavault AI is a micro‑cap AI‑driven medtech company trading on Nasdaq.
Ticker impact
Q2 2026 results showed a widened net loss of $18.36M and a 10.3% pre‑market slide.
Further downside pressure in intraday trading.
Loss expansion, debt extinguishment cost, and dilution raise capital adequacy concerns.
Market effects
Highlights financing challenges for micro‑cap AI medtech firms.
Limited to US small‑cap investors.
Minimal beyond niche AI/medtech sector.
Counterpoint
If the acquisition of CyberCatch delivers strategic value, the stock could rebound.
Key entities
- companyDatavault AI Inc.
AI‑focused medtech firm reporting Q2 2026 results.
- investorStreeterville Capital
Provider of a $25M convertible note and 15M shares.
- targetCyberCatch Holdings
Proposed $94.5M cash acquisition target.



